Dr Reddy's Introduces OTC Drug In US Market
In a declaration, Dr Reddy's Laboratories stated that Fexofenadine HCl and Pseudoephedrine HCl extended release tabs in the potencies of 180 and 240 mg have been rolled out in the US market.
Over-The-Counter (OTC) medications can be bought without any recommendation and are commonly utilized to treat symptoms of common sicknesses, which may not need the direct care of a medical doctor.
The US Food and Drug Administration (USFDA) had sanctioned the Hyderabad-based company's abbreviated new drug application (ANDA) for the tabs on June 22, 2011.
"Dr Reddy's will market the product under store brand labels in the US market," the company said.
The company's product is a bio equivalent edition of Sanofi Aventis' Allegra D24 Hour extended release tabs.
=================================================
=================================================
Dr Reddy's Laboratories stated that it has introduced two over-the-counter (OTC) medicines utilized to take care of seasonal allergic reactions like itchy nose and sneezing, in the US market.In a declaration, Dr Reddy's Laboratories stated that Fexofenadine HCl and Pseudoephedrine HCl extended release tabs in the potencies of 180 and 240 mg have been rolled out in the US market.
Over-The-Counter (OTC) medications can be bought without any recommendation and are commonly utilized to treat symptoms of common sicknesses, which may not need the direct care of a medical doctor.
The US Food and Drug Administration (USFDA) had sanctioned the Hyderabad-based company's abbreviated new drug application (ANDA) for the tabs on June 22, 2011.
"Dr Reddy's will market the product under store brand labels in the US market," the company said.
The company's product is a bio equivalent edition of Sanofi Aventis' Allegra D24 Hour extended release tabs.
=================================================
No comments:
Post a Comment